Perspectives in Cholesterol-Lowering Therapy
Author:
Affiliation:
1. From the Service d’Endocrinologie-Métabolisme, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Link
https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000072345.98581.24
Reference20 articles.
1. Current Perspectives on Statins
2. Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
3. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
4. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
5. New Advances in Lipid-Modifying Therapies for Reducing Cardiovascular Risk
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting;The American Journal of the Medical Sciences;2024-02
2. Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation;International Journal of Molecular Sciences;2023-11-08
3. Microbial oil, alone or paired with β-glucans, can control hypercholesterolemia in a zebrafish model;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2023-11
4. Current and future options in cholesterol lowering treatments;European Journal of Internal Medicine;2023-06
5. UV–visible absorption spectroscopy for in-line API concentration measurement in nanoparticle production process using controlled expansion of supercritical solutions (CESS®);Journal of Pharmaceutical and Biomedical Analysis;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3